Table I.
Demographic characteristics and plasma levels of lipids and inflammatory markers in CAD(1–3) and CAD(0) patients.
| Variable | CAD(0) patients | CAD(1–3) patients | P-value |
|---|---|---|---|
| N | 43 | 50 | |
| Male/female, (N) | 21/22 | 38/12 | 0.011 |
| Age, y | 60.43±12.44 | 61.32±10.79 | 0.671 |
| BMI, kg/m2 | 26.32±3.27 | 27.11±3.94 | 0.207 |
| HT, % | 34.9 | 28.0 | 0.559 |
| Smokers, % | 40.9 | 76.0 | 0.010 |
| W/H ratio | 0.91±0.10 | 0.96±0.09 | 0.003 |
| TC, mmol/L | 4.89±1.13 | 5.05±1.87 | 0.542 |
| TG, mmol/L* | 1.41 (1.22–1.63) | 1.57 (1.33–1.86) | 0.174 |
| HDL-C, mmol/L | 1.24±0.32 | 1.08±0.32 | 0.006 |
| LDL-C, mmol/L | 2.94±0.93 | 3.20±1.44 | 0.215 |
| hsCRP, mg/L* | 2.71 (1.81–4.05) | 5.83 (3.53–9.63) | 0.001 |
| PTX3 * | 3.96 (3.13–5.01) | 6.72 (4.58–9.85) | <0.001 |
Continuous variables are presented as mean ±1 SD, and categorical variables are presented as absolute and relative frequencies.
*
For TG, hs-CRP and PTX3 the geometrical mean and 95% confidence interval (CI) are presented
(BMI – body mass index; HT – hypertension; W/H – waist-to-hip ratio; TC – total cholesterol; TG – triglycerides; HDL-C – HDL-cholesterol; LDL-C – LDL-cholesterol; hsCRP – high-sensitivity C-reactive protein; PTX3 – pentraxin-3).